https://doi.org/10.1038/cddis.2016.140
Z
Z. Ma
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
115
Papers
1.7K
Citations
20
h-index
31
i10-index
Z. Ma is an academic researcher from Ningbo University. The author has contributed to research in topics: Lung Cancer Treatments and Mutations & Cancer Immunotherapy and Biomarkers & Lung Cancer Diagnosis and Treatment. The author has an h-index of 20, co-authored 98 publications.
ORCID: 0009-0007-2543-0735Papers by this author
worksThe emerging role of Toll-like receptor 4 in myocardial inflammation
2016 · Cell Death and Disease · 319 citations
Consensus for HER2 alterations testing in non-small-cell lung cancer
2022 · ESMO Open · 105 citations
https://doi.org/10.1016/j.esmoop.2022.100395
Itaconate transporter SLC13A3 confers immunotherapy resistance via alkylation-mediated stabilization of PD-L1
2025 · Cell Metabolism · 32 citations
https://doi.org/10.1016/j.cmet.2024.11.012
Tislelizumab plus chemotherapy as first-line treatment of locally advanced or metastatic nonsquamous non-small-cell lung cancer (final analysis of RATIONALE-304: a randomized phase III trial)
2024 · ESMO Open · 26 citations
https://doi.org/10.1016/j.esmoop.2024.103728
The influence of hospital services on patient satisfaction in OPDs: evidence from the transition to a digital system in South Punjab, Pakistan
2024 · Health Research Policy and Systems · 14 citations
https://doi.org/10.1186/s12961-024-01178-8
Field molecular epidemiology. Feasibility of monitoring for the malignant bladder cell phenotype in a benzidine-exposed occupational cohort.
1993 · PubMed · 12 citations
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat